Berto, P. et al. 2022. Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy. Farmeconomia. Health economics and therapeutic pathways. 23, 1 (Feb. 2022). DOI:https://doi.org/10.7175/fe.v23i1.1516.